// App-Quantinova.ai

P6-16-04 : IL6ST, a biomarker of endocrine therapy response, has potential in identifying a subgroup of women with ER+ DCIS who are more likely to benefit from adjuvant endocrine therapy

Researchers

Presenter

  • Carlos Martinez-Perez

Principal Investigators

  • Charlene Kay

  • Rebecca Swan

  • Gregory E Ekatah

  • Laura M Arthur

  • James Meehan

  • Mark Gray

  • Andrew H Sims

  • Olga Oikonomidou

  • Arran K Turnbull

  • J Michael Dixon

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved